AMAB (adalimumab biosimilar) / Vital Brazil Institute, Axis Biotec - LARVOL DELTA

Adalimumab Vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A Geteccu Randomized Trial. (PubMed) - J Crohns Colitis - P3; "Postoperative recurrence of Crohn's disease (POR-CD) is almost certain if no prophylaxis is administered. ADA has not demonstrated a better efficacy than AZA (both associated to metronidazole) for prophylaxis of POR-CD in an unselected population, although tolerance to ADA is significantly better. ClinicalTrials.gov NCT01564823."

Journal • Biosimilar • Crohn's disease • Immunology • Inflammatory Bowel Disease